vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Mastech Digital, Inc. (MHH). Click either name above to swap in a different company.
Mastech Digital, Inc. is the larger business by last-quarter revenue ($45.5M vs $38.3M, roughly 1.2× ImmunityBio, Inc.). Mastech Digital, Inc. runs the higher net margin — 2.1% vs -161.8%, a 163.9% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -10.4%). Mastech Digital, Inc. produced more free cash flow last quarter ($4.3M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
IBRX vs MHH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $38.3M | $45.5M |
| Net Profit | $-61.9M | $972.0K |
| Gross Margin | 99.0% | 28.3% |
| Operating Margin | -169.0% | 2.2% |
| Net Margin | -161.8% | 2.1% |
| Revenue YoY | 407.0% | -10.4% |
| Net Profit YoY | -4.7% | 227.3% |
| EPS (diluted) | $-0.06 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $45.5M | ||
| Q3 25 | $32.1M | $48.5M | ||
| Q2 25 | $26.4M | $49.1M | ||
| Q1 25 | $16.5M | $48.3M | ||
| Q4 24 | $7.6M | $50.7M | ||
| Q3 24 | $6.1M | $51.8M | ||
| Q2 24 | — | $49.5M | ||
| Q1 24 | — | $46.8M |
| Q4 25 | $-61.9M | $972.0K | ||
| Q3 25 | $-67.3M | $941.0K | ||
| Q2 25 | $-92.6M | $135.0K | ||
| Q1 25 | $-129.6M | $-1.4M | ||
| Q4 24 | $-59.2M | $297.0K | ||
| Q3 24 | $-85.7M | $1.9M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $-161.0K |
| Q4 25 | 99.0% | 28.3% | ||
| Q3 25 | 99.4% | 27.8% | ||
| Q2 25 | 99.5% | 28.1% | ||
| Q1 25 | 99.6% | 26.7% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 28.5% | ||
| Q2 24 | — | 28.2% | ||
| Q1 24 | — | 25.9% |
| Q4 25 | -169.0% | 2.2% | ||
| Q3 25 | -173.5% | 1.7% | ||
| Q2 25 | -269.8% | 0.1% | ||
| Q1 25 | -390.1% | -3.8% | ||
| Q4 24 | -919.0% | 0.1% | ||
| Q3 24 | -1314.3% | 4.7% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -0.9% |
| Q4 25 | -161.8% | 2.1% | ||
| Q3 25 | -209.8% | 1.9% | ||
| Q2 25 | -350.3% | 0.3% | ||
| Q1 25 | -784.9% | -3.0% | ||
| Q4 24 | -783.4% | 0.6% | ||
| Q3 24 | -1404.0% | 3.6% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | -0.3% |
| Q4 25 | $-0.06 | $0.08 | ||
| Q3 25 | $-0.07 | $0.08 | ||
| Q2 25 | $-0.10 | $0.01 | ||
| Q1 25 | $-0.15 | $-0.12 | ||
| Q4 24 | $-0.08 | $0.01 | ||
| Q3 24 | $-0.14 | $0.16 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $36.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $89.3M |
| Total Assets | $501.9M | $111.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $36.5M | ||
| Q3 25 | $257.8M | $32.7M | ||
| Q2 25 | $153.7M | $27.9M | ||
| Q1 25 | $61.6M | $24.7M | ||
| Q4 24 | $149.8M | $27.7M | ||
| Q3 24 | $130.4M | $23.9M | ||
| Q2 24 | — | $20.6M | ||
| Q1 24 | — | $19.4M |
| Q4 25 | $-500.5M | $89.3M | ||
| Q3 25 | $-524.3M | $88.0M | ||
| Q2 25 | $-570.7M | $87.8M | ||
| Q1 25 | $-591.4M | $86.9M | ||
| Q4 24 | $-489.1M | $87.4M | ||
| Q3 24 | $-745.1M | $86.5M | ||
| Q2 24 | — | $84.0M | ||
| Q1 24 | — | $81.7M |
| Q4 25 | $501.9M | $111.8M | ||
| Q3 25 | $519.0M | $112.6M | ||
| Q2 25 | $402.1M | $110.4M | ||
| Q1 25 | $303.8M | $110.1M | ||
| Q4 24 | $382.9M | $111.5M | ||
| Q3 24 | $364.6M | $111.5M | ||
| Q2 24 | — | $107.5M | ||
| Q1 24 | — | $106.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $4.4M |
| Free Cash FlowOCF − Capex | $-71.3M | $4.3M |
| FCF MarginFCF / Revenue | -186.2% | 9.5% |
| Capex IntensityCapex / Revenue | 2.4% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 4.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $10.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $4.4M | ||
| Q3 25 | $-68.9M | $6.5M | ||
| Q2 25 | $-79.7M | $3.3M | ||
| Q1 25 | $-85.9M | $-3.0M | ||
| Q4 24 | $-85.1M | $4.0M | ||
| Q3 24 | $-98.8M | $3.3M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | $-71.3M | $4.3M | ||
| Q3 25 | $-69.6M | $6.3M | ||
| Q2 25 | $-80.8M | $3.2M | ||
| Q1 25 | $-87.0M | $-3.1M | ||
| Q4 24 | $-87.3M | $3.9M | ||
| Q3 24 | $-101.6M | $3.2M | ||
| Q2 24 | — | $707.0K | ||
| Q1 24 | — | $-1.6M |
| Q4 25 | -186.2% | 9.5% | ||
| Q3 25 | -217.2% | 13.0% | ||
| Q2 25 | -305.9% | 6.6% | ||
| Q1 25 | -526.9% | -6.4% | ||
| Q4 24 | -1155.4% | 7.7% | ||
| Q3 24 | -1663.2% | 6.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | -3.4% |
| Q4 25 | 2.4% | 0.1% | ||
| Q3 25 | 2.3% | 0.4% | ||
| Q2 25 | 4.1% | 0.1% | ||
| Q1 25 | 6.8% | 0.2% | ||
| Q4 24 | 28.0% | 0.2% | ||
| Q3 24 | 45.7% | 0.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 4.48× | ||
| Q3 25 | — | 6.88× | ||
| Q2 25 | — | 24.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 13.60× | ||
| Q3 24 | — | 1.76× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBRX
Segment breakdown not available.
MHH
| IT Staffing Services | $37.6M | 83% |
| Data And Analytics Services | $7.8M | 17% |